The Centers for Medicare & Medicaid Services announced Sept. 28 that it projects declines in average premiums for Medicare Advantage and Part D in 2027.
Prescription Drugs
The Centers for Medicare & Medicaid Services announced Sept. 18 that all 50 states, Washington, D.C., and Puerto Rico have applied to participate in its initiative to make certain prescription drugs available to people with Medicaid at prices aligned with those paid in other countries, known as…
The AHA's principal recommendation is that CMS use its authority to require drug manufacturers to make the Maximum Fair Price (MFP) available through a prospective, point-of-sale mechanism and eliminate any option that would permit manufacturers to satisfy their obligations through retrospective…
The Centers for Medicare & Medicaid Services July 14 issued a proposed rule that would update physician fee schedule (PFS) payments for calendar year (CY) 2027.
The Food and Drug Administration June 22 announced multiple actions to help accelerate early- and late-stage drug development.
Although drug diversion occurs infrequently, Dartmouth Health developed a Drug Diversion Prevention Program to further strengthen its protocols and minimize the potential for the mishandling of medications.
The Department of Health and Human Services yesterday announced an action plan on psychiatric prescribing, including efforts to initiate deprescribing based on clinical indicators, “especially among children.” HHS said its agencies will evaluate prescription patterns for psychiatric…
President Trump April 18 signed an executive order to accelerate research into psychedelic drugs for the treatment of serious mental illnesses, calling out ibogaine compounds as an example of such psychedelics. While the order does not mandate a change in drug schedule for these…
The AHA supports efforts to reform prior authorization and reduce the significant administrative burden these practices impose on hospitals, clinicians and patients. Prior authorization requirements for prescription drugs, particularly specialty and high‑cost medications, frequently result in care…
CMS Issues Final Rule for CY 2027 Medicare Advantage, Prescription Drug Plans and 2027 MA Rate announcement.